Search for: "Astrazeneca"
Results 1161 - 1180
of 1,246
Sort by Relevance
|
Sort by Date
3 Feb 2008, 9:47 pm
Astrazeneca Pharmaceuticals LP et al. 8:08-cv-00213; filed January 31, 2007 in the Middle District of Florida... [read post]
25 Jan 2008, 1:00 am
: (Generic Pharmaceuticals & IP),Arava (Leflunomide) - Sanofi-Aventis loses bid to dismiss Louisiana Wholsesale Drug Co's antitrust claims accusing S-A of unlawfully blocking generic competition for Arava by filing a sham Citizen Petition with the USFDA: (IP Law360),Ciprofloxacin - CIPLA issued notice by National Pharmaceutical Pricing Authority for allegedly overpricing its antibiotic Ciprofloxacin (especially of note because CIPLA is objecting… [read post]
20 Jan 2008, 6:55 pm
AstraZeneca AB et al. v. [read post]
17 Jan 2008, 10:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at [feeds.feedburner.com]Highlights this week included:The European antitrust raids on Pfizer, AstraZeneca, Glaxo, Sanofi-Aventis: (IP Law360), (Wall Street Journal Health Blog), (IAM), (IPEG), (SmartBrief), (In the pipeline),Hasbro and Mattel alleged trade mark infringement and demand shut down of Scrabulous, a free online gaming site allowing users to play a version of… [read post]
17 Jan 2008, 6:00 pm
Esomeprazole is a proton pump inhibitor (brand names Nexium ®; Lucen ®; Esopral ® and Axagon ® in Italy) developed and marketed by AstraZeneca which is used in the treatment of dyspepsia, peptic ulcer disease (PUD), gastroesophageal reflux disease (GORD/GERD) and Zollinger-Ellison syndrome. [read post]
7 Jan 2008, 8:48 pm
Astrazeneca Pharmaceuticals LP et al. v. [read post]
7 Jan 2008, 12:35 pm
AstraZeneca's creative marketing efforts do not stop there. [read post]
7 Jan 2008, 12:35 pm
AstraZeneca's creative marketing efforts do not stop there. [read post]
5 Jan 2008, 6:00 am
You can separately subscribe to the IP Think Tank Global week in Review at [feeds.feedburner.com]GlobalComing out of copyright - some notable deaths from 1937: (IPKat),Design patents: No longer the province of individual inventors: (Patently O),Fail fast, ready fire aim and Stanford v Cal: (IP Think Tank),Walls, Alexander the Great and Partha Bose: (IP Think Tank),A fair use primer for online content creators: (Ars Technica)ISO moves to create global… [read post]
27 Dec 2007, 11:00 pm
AstraZeneca announced on December 12 that it filed patent infringement suits against seven generic drug makers who filed ANDAs for generic versions of Crestor (rasuvastatin calcium). [read post]
14 Dec 2007, 1:00 am
: (Patent Prospector) PharmaAggregate launches new online presence: (MaRS Blog - Innovation and Commercialization in Canada)Japan Plans Generic Drug Incentives to Cut Down Medical Costs: (MedIndia), Interesting commentary and article on generic/ innovator company patent settlements: (Generic Pharmaceuticals & IP), Global trends in commencement of patent actions by innovators: (Generic Pharmaceuticals & IP), Is marketing and not … [read post]
13 Dec 2007, 2:09 am
The antipsychotics include AstraZeneca's Seroquel, Eli Lilly's Zyprexa and Johnson & Johnson's Risperdal and all contain a black box warning on their labeling saying the drugs are associated with an increased risk of death in elderly patients with dementia.Go get ‘em Senator Grassley! [read post]
8 Dec 2007, 11:00 am
: (IP Think Tank), WIPO - Idris gets paid out to leave early: (IAM), (Patent Prospector), Deutsche Grammophon ditches DRM: (ArsTechnica)PharmaFDA revisits NCE exclusivity for enantiomers: (Arnall Golden & Gregory), Accupril (Quinapril) - Judge finds against Teva and holds Warner-Lambert patent enabled: (IPLaw360), (OrangeBookBlog), Altace / Tritace / Ramace (Ramipril) - King Pharmaceuticals loses CAFC rehearing bid: (IPLaw360), … [read post]
7 Dec 2007, 12:08 pm
AstraZeneca reported $5.2 billion in Nexium sales for last year.Presuming the FDA renders it opinion about the safety of Nexium and Prilosec in the next couple of weeks, AstraZeneca will soon know whether the FDA is its Santa or its Grinch this holiday season. [read post]
4 Dec 2007, 8:02 am
AstraZeneca says it "does not recommend Seroquel for uses other than its approved indications in schizophrenia and bipolar disorder. [read post]
23 Nov 2007, 9:00 am
Astra's Data Exclusivity prevents a European generic launch, until at least 2010.: (Generic Pharmaceuticals & IP), Iressa (gefitinib) - Astrazeneca's Indian patent application rejected: (Generic Pharmaceuticals & IP), Ziagen (Abacavir Hemisulfate Salt) -GSK's application [872/CAL/98; corresponding to Orange Book listed US6294540] opposed by Indian Network for People living with HIV/ AIDS and then withdrawn by GSK: (Generic Pharmaceuticals & IP), Thai… [read post]
21 Nov 2007, 5:21 am
AstraZeneca Pharmacerticals, L.P., 958 So. 2d 1054 (Fla. [read post]
20 Nov 2007, 10:18 pm
13 Nov 2007, 11:18 pm
In exchange, Barr received a $21 million payment and entered an agreement with AstraZeneca under which Barr sold generic tamoxifen provided by AstraZeneca.Consumers filed a lawsuit challenging the agreement. [read post]
8 Nov 2007, 7:37 pm
In May 2006, AstraZeneca... [read post]
